Association between Ki-67 and clinical outcomes in 324 Chinese patients with resectable acral melanoma
The relationship between Ki-67 expression and clinical prognosis in patients with resectable acral melanoma (AM) remains unclear. This study explores the prognostic role of Ki-67 in AM using data from 324 patients across five Chinese centers. Patients were divided into low Ki-67 expression and high Ki-67 expression groups based on pathological reports. The log-rank test was used to compare disease-free survival (DFS) and overall survival (OS), and the Cox proportional hazards regression model was employed to identify prognostic factors. Among the 324 patients included in the study, 181 (55.8%) were in the low Ki-67 expression group, and 143 (44.2%) were in the high Ki-67 expression group. The high Ki-67 expression group exhibited a higher incidence of tumor thickness > 4 mm (45.5% vs 24.3%, P < 0.001), ulceration (65.7% vs 54.1%, P = 0.035), stage III (31.5% vs 16.0%, P < 0.001), LDH ≥ 250 U/L (14.0% vs. 6.6%, P = 0.028), and positive sentinel lymph nodes (28.0% vs 11.1%, P = 0.029). High Ki-67 predicted shorter DFS (26.8 vs 74.1 months, P = 0.025) and OS (52.1 months vs NR, P < 0.001). Multivariate analysis identified Ki-67, age, stage and LDH as independent OS predictors.
Authors
- Weizhen Zhang (ORCID: https://orcid.org/0000-0001-8791-2798)
- Hongxue Meng (ORCID: https://orcid.org/0000-0002-1831-2737)
- Di Wu (ORCID: https://orcid.org/0000-0003-1870-798X)
- Jianping Gui (ORCID: https://orcid.org/0000-0001-7586-8582)
- Jiwei Liu (ORCID: https://orcid.org/0000-0002-4010-3026)
- Yan Wang (ORCID: https://orcid.org/0000-0003-4779-9967)
- Mei Xiang (ORCID: https://orcid.org/0000-0002-9199-6637)
- Hongfeng Zhou
- Yi Teng (ORCID: https://orcid.org/0009-0000-4968-3787)
- Fang Liu (ORCID: https://orcid.org/0000-0002-5379-8816)
- Xin Cai (ORCID: https://orcid.org/0009-0002-3126-4976)
- Jin Wu (ORCID: https://orcid.org/0000-0003-2430-3172)
- Zhen Guo (ORCID: https://orcid.org/0000-0003-3967-4304)
- Kui Jiang (ORCID: https://orcid.org/0000-0002-4055-7503)
- Xiang Ji
Institutions
- Harbin Medical University (CN)
- Dalian Medical University (CN)
- Jilin University (CN)
- Second Affiliated Hospital of Dalian Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- First Hospital of Jilin University (CN)
- Changchun University of Chinese Medicine (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Third Affiliated Hospital of Zhengzhou University (CN)
- Zhengzhou People's Hospital (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-08-17
- DOI
- https://doi.org/10.1038/s41598-025-15751-w
- Citations
- 1
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 2.00